PA
PGEN icon

Parallel Advisors’s Precigen PGEN Stock Holding History

Parallel Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-522
Closed -$2.18K – 3929
2025
Q4 		$2.18K Buy
+522
New +$2.02K ﹤0.01% 3109
2018
Q4 		– Sell
-219
Closed -$4K – 2234
2018
Q3 		$4K Hold
219
– – ﹤0.01% 1813
2018
Q2 		$3K Hold
219
– – ﹤0.01% 1758
2018
Q1 		$3K Buy
+219
New +$3.13K ﹤0.01% 1750
2017
Q1 		– Sell
-2,951
Closed -$71K – 2058
2016
Q4 		$71K Buy
+2,951
New +$82.1K 0.02% 478

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Parallel Advisors's PGEN Position: Q1 2026 in Review

Parallel Advisors sold out of Precigen (PGEN) in Q1 2026, closing a stake of 522 shares — an estimated $2.18K sold.

Parallel Advisors first reported a position in PGEN in Q4 2016 and held it in 5 quarters. The position peaked at $71K in Q4 2016. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Parallel Advisors reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • Parallel Advisors sold 522 Precigen shares in Q1 2026, an estimated $2.18K.
  • Parallel Advisors first reported a position in Precigen in Q4 2016 and held it in 5 quarters.
  • Parallel Advisors's Precigen position peaked at $71K in Q4 2016.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.